A cDNA clone expressing a Plasmodium falciparum blood-stage antigen in Escherichia coli was identified by colony immunoassay using immune human sera. Antibodies affinity-purified on extracts of this clone reacted with both asexual blood stages and sporozoites of P.
Plasmodium falciparum, the major cause of human malaria, has a complex life cycle. Sporozoites, injected by the mosquito vector, rapidly enter liver cells and disappear from the peripheral circulation within minutes (1) . After a period of nuclear division within the hepatocyte, many merozoites are released to commence the erythrocytic cycle, which lasts days or weeks in the absence of treatment. Immunization with irradiated sporozoites gave substantial protection in mice and humans against subsequent sporozoite challenge (2, 3) but not against challenge with asexual blood stages (4) . Sera collected from the immunized individuals reacted in an immunofluorescence assay with sporozoites but not blood stages (5) . These findings were taken to discount the possibility of cross protection between these stages and implied slight or no cross-reaction between surface antigens.
Hope et al. (6) have recently described a monoclonal antibody raised against blood stages of P. falciparum that recognized a protein of Mr 23,000. Immunofluorescence studies on fixed preparations showed that this monoclonal antibody reacted with asexual blood stages and sporozoites, suggesting that at least one epitope was shared between stages.
P. falciparum sporozoites have a dominant coat protein (7) , the circumsporozoite protein (CSP), the sequence of which has recently been determined (8, 9) . The CSP contains many repeats of a tetrameric sequence. Preincubation with monoclonal antibodies directed against this repeat abrogated the infectivity of sporozoites (7) . We have recently reported the production ofP. falciparum proteins in Escherichia coli (10) (11) (12) . Many distinct antigens were detected by reaction of cloned proteins with sera from immune individuals. We report the detailed characterization of one such antigen identified in this way, a Mr 23, 000 polypeptide that shares sequences with the repeat peptide of the CSP of P. falciparum. We show that human antibodies that react with this polypeptide also react with sporozoites.
MATERIALS AND METHODS
Preparation of Affinity-Purified Antibodies Against Ag6l Protein. Induced 50-ml cultures of E. coli carrying cDNA clone Ag6l and expression vector XAmp3 were prepared. The pelleted bacteria were sonicated in 100 mM sodium phosphate buffer, pH 6.8 (Ps)/10 mM dithiothreitol followed by mixing at room temperature with 1% NaDodSO4. The soluble bacterial proteins were equilibrated with Pi/1 mM dithiothreitol/0.1% NaDodSO4 by passage through Sephadex G-10 and conjugated to CNBr-activated Sepharose (Pharmacia, Sweden) at room temperature. A pool of human sera collected from individuals in Papua New Guinea was clarified by centrifugation, diluted with an equal volume of phosphate-buffered saline (Pi/NaCI), and preabsorbed on a XAmp3-Sepharose absorbent before being passed over the Ag6l absorbent. Nonspecifically bound proteins were removed by repeated wash cycles of 100 mM sodium borate/500 mM NaCl/0.05% Tween 20, pH 8.5, followed by P,/NaCl. Bound antibodies were eluted with 100 mM glycine/150 mM NaCl, pH 2.6, and immediately neutralized with 2 M Tris HCl, pH 8.0.
Immunoblots. In vitro cultures of P. falciparum were synchronized by treatment with 5% sorbitol (13) . Protein extracts of cultures of P. falciparum were prepared and fractionated on 10% polyacrylamide/NaDodSO4 gels. Proteins from the gels were transferred electrophoretically to nitrocellulose (14) and incubated in 5% nonfat milk powder in Pi/NaCl before reaction with affinity-purified human antiserum. The filters were incubated with 125I-labeled staphylococcal protein A and autoradiographed.
Immunofluorescence (16) was employed for sequence determinations. The Ag6l cDNA insert and fragments generated from it by restriction enzyme digestion were cloned into phages M13mp8 and -9 (17).
Southern Hybridization. P. falciparum DNA was digested with restriction endonucleases and fractionated on 1% agarose gels. The DNA was transferred to nitrocellulose and prepared for hybridization by the method of Southern (18) . Hybridization probes were prepared by nick-translation of DNA fragments purified by agarose gels electrophoresis. Filters were washed in 0.30 M NaCl/0.03 M sodium citrate at 650C.
RESULTS
Identification of the P.falciparum Antigen Corresponding to Ag6l. Clone Ag6l (Ag6l) was one of 78 clones identified by screening a P. falciparum cDNA library in the expression vector XAmp3, as described (10, 11, 19) . To identify the P. falciparum antigen expressed by clone Ag61, sera collected from adults living in the Madang province of Papua New Guinea were depleted of antibodies to E. coli by passage over a XAmp3 absorbent before affinity purification on clone Ag6l. They were then used to characterize the corresponding antigen of P. falciparum by immunoblotting and immunofluorescence.
Highly purified populations of rings, trophozoites, schizonts, and merozoites from P. falciparum isolate FC27 were analyzed for the presence of polypeptides corresponding to Ag6l. As shown in Fig. LA , a dominant Mr 23,000 polypeptide was detected in all of the asexual stages. In the merozoite preparation two high molecular weight polypeptides (Mr 143,000 and 70,000) were detected, as were several smaller forms ranging in molecular weight from 18,000 to 23,000. It would appear from the nucleotide (20) . Tracks 1-4 were prepared from rings, trophozoites, schizonts, and merozoites, respectively. Track 5, molecular weight markers. (B and C) Detergent extracts of an asynchronous in vitro culture of the FC27 isolate of P. falciparum (track 1) and of induced cultures of E. coli infected with Ag6l (track 2) and with XAmp3 (track 3). In A and B the probe was affinitypurified human anti-Ag6l, and in C the probe was serum collected from an adult living in Madang, Papua New Guinea.
sequence data (see below) that the larger polypeptides are cross-reactive antigens unique to the merozoite, rather than precursors of the smaller polypeptides. When other isolates of P. falciparum were examined (K1, Thailand; V1, Vietnam; and NF7, Ghana) the same dominant Mr 23,000 polypeptide was present (data not shown).
Immunoblots on protein extracts from Ag6l with these purified human antibodies revealed that the antigen was expressed in E. coli in two major forms, Mr 25,000 and Mr 21,000 (Fig. 1B) . Long exposures show that a Mr 25,000 form is also present in P. falciparum. It is therefore likely that the Mr 25,000 form is a full-length precursor in both E. coli and P. falciparum but the processing differs. These precursor forms are also detectable by using whole human sera (Fig.  1C) .
Localization of the antigen in the parasite was studied by indirect immunofluorescence microscopy on slides prepared from fixed asynchronous cultures of FC27. Fluorescence was prominent in the trophozoite and schizont, where it appeared diffuse and granular and not apparently localized to membranes or organelles ( Fig. 2A) . There was also fluorescence detectable on the ring stage, the fluorescence appearing in a rim around the parasite ( Fig. 2A ). This contrasts with the characteristic location of the ring-infected erythrocyte surface antigen (RESA), which is localized at the membrane of the ring-infected erythrocyte (21) . Immunofluorescence studies on the other P. falciparum isolates gave results similar to those with FC27 (data not shown).
Determination of the Nucleotide Sequence of Ag6l. DNA was prepared from clone Ag6l and digested with EcoRI to release the P. falciparum insert. Examination of digestion products by agarose gel electrophoresis revealed that four distinct DNA segments had been ligated into the XAmp3 phage, as observed for some other clones (11) . To identify the expressed DNA segment, each segment was recloned separately in XAmp3 and tested for expression of Ag6l sequences by reaction with affinity-purified human antibodies to Ag6l protein. The expressing insert was then subcloned in an M13 vector and sequenced by the dideoxy method (16) . The nucleotide sequence and derived amino acid sequence are presented in Fig. 3 Conservation of Restriction Sites Flanking the Ag6l Gene. The genomic context of Ag6l was examined in three parasite isolates-namely, FC27 from Papua New Guinea, K1 from Thailand, and NF7 from Ghana. DNA from each isolate was digested with either EcoRI or HindIII, electrophoretically separated on an agarose gel and transferred to nitrocellulose (18) , and probed with radioactively labeled Ag6l DNA. The size of hybridizing bands, 21.5 kilobases (kb) for EcoRI and 5.9 kb for HindIII, is constant for each isolate (Fig. 5) , suggesting that the genomic context of this gene is preserved in isolates from widely separated regions.
Specificity and Prevalence of Antibodies to Ag6l Protein. The unexpected finding of sequences within the coding sequence of Ag6l that are shared with the CSP suggested that antibodies purified on lysates of Ag6l would react with P. falciparum sporozoites. Accordingly, affinity-purified antibodies to Ag6l protein were allowed to react with air-dried sporozoites of P. falciparum and P. vivax. Anti-Ag6l antibodies reacted with P. falciparum sporozoites (Fig. 2B) but not with P. vivax sporozoites, with positive fluorescence still readily detectable at a titer of 1:1200. Sixteen sera from individuals living in an area in which P. falciparum is endemic were tested in the colony immunoassay for antibodies directed against Ag6l protein. Eight sera (50%) had detectable levels of antibody as measured in this relatively insensitive assay (data not shown).
DISCUSSION
We have presented here the complete nucleotide sequence of a P. falciparum asexual blood stage antigen. It is unusual among P. falciparum antigens already described (12, 21, 23, 24) in that it is a small protein, it does not contain any tandemly repeating peptides, and there is no polymorphism in size of this protein amongst isolates. These features are linked, as the large size and polymorphism of P. falciparum antigens such as the S antigen, RESA, and the falciparum interspersed repeat antigen are contributed to by the presence of these repeats (12, 21, 23) .
Although there are no authentic repeats in this antigen, the region bounded by nucleotides 498 and 569 contains a number of internal homologies-in particular, the two tetramers Asn-Ala-Asn-Pro and Asn-Ala-Asp-Pro. Surprisingly, the first of these related tetramers is the dominant repeat found in the CSP of P. falciparum (8, 9) . The CSP is composed of 37 repeats of Asn-Ala-Asn-Pro and 4 repeats of Asn-ValAsp-Pro. There are eight different combinations of nucleotides that code for the tetramer Asn-Ala-Asn-Pro in the CSP, all of which differ from the coding sequence found in Ag6l. This suggests that the tetramer in Ag6l could not be derived from the CSP by shuffling of repeat sequences around the genome. Because of the presence of these tetramers we have designated this protein the circumsporozoite protein-related antigen (CRA).
The presence of a long hydrophobic stretch is consistent with an anchor sequence of an integral membrane protein.
The fluorescence pattern suggests that CRA may be associated with the surface of the ring stage parasite within the erythrocyte (see Fig. 1B The CRA is found in many parasite strains. In this study it was found in 4 of 4 strains. Studies by Hall et al. (28) , using a monoclonal antibody that we believe to be directed against the same protein, found it in 22 of 27 strains studied. Antibodies to it are common, being present in 50o of sera that we assayed. We have examined 16 sera that had previously been assayed for their ability to inhibit the growth of the parasite in vitro. These sera were divided into two groups: those causing greater than 50% inhibition of growth, and those causing less than 25% growth inhibition. When these sera were assayed against a clone producing CRA in a colony immunoassay, there was a correlation between anti-CRA antibody and the ability to inhibit in vitro growth significant at P < 0.05 (data not shown). If purified anti-CRA antibodies are found to inhibit growth, it raises the possibility of a single unit malaria vaccine active against both sporozoites and blood stages.
After the completion of the work described in this paper Hope et al. (26) reported the nucleotide sequence of a protein that they designated Ag5.1. A monoclonal antibody that reacted with clone Ag5.1 also reacted with sporozoites, in accordance with our data on human antibodies. The sequence is identical to that of the CRA except for an A-to-G transition at codon 28, resulting in a change from glutamate to glycine. This conservation of sequence is interesting in view of the widely differing sequences reported for the S antigen of P. falciparum (27) , the only other P. falciparum protein for which sequences from two strains are available.
